Annual Drug Patent Expirations for KENGREAL
Kengreal is a drug marketed by Chiesi and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug.
Drug patent litigation for KENGREAL.
This drug has ninety-six patent family members in forty-one countries.
The generic ingredient in KENGREAL is cangrelor. One supplier is listed for this compound. Additional details are available on the cangrelor profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
